Profound Medical Corp.

PROFNASDAQHealthcare● Active

$6.57

$-0.09(-1.35%)

Market Cap$198804245

P/E Ratio—

52W High$8.95

52W Low$3.76

Avg Volume182K

Open$6.68

Beta0.72

Cash on Hand Financials Revenue

Profound Medical Corp. (PROF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

PROF · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$81.8M▲ +49.0% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$81.8M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

+49.0%

vs prior fiscal year

Latest Quarter

$50.5M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$81.8MCash on Hand

Total Debt$6.5MTotal Debt

Net Cash / Net Debt+$75.3MNet Cash Position

Cash vs Debt Ratio

Cash 93%Profound Medical Corp. cash as % of market cap: 41.15%% · MCap $0BDebt 7%

Profound Medical Corp. has a net cash position of $75.3M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$81.8M − $6.5M = +$75.3M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

PROF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

PROF cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$81.8M+49.0%

Dec 31, 2024FY$54.9M+109.5%

Dec 31, 2023FY$26.2M-43.6%

Dec 31, 2022FY$46.5M-30.6%

Dec 31, 2021FY$67.1M-20.1%

PROF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

PROF vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Profound Medical Corp.YOU

PROF

$81.8M$199M41.1%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Profound Medical Corp. (PROF) cash on hand as of December 31, 2025 is $81.8M, comprising $81.8M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Profound Medical Corp. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Profound Medical Corp. cash reserves or cash position.

Profound Medical Corp. annual cash on hand history shows increased +49.0% in 2025: increased +49.0% in 2025. Profound Medical Corp. cash reserves in 2025 reflect the company's capital allocation strategy.

Profound Medical Corp. carries total debt of $6.5M against cash of $81.8M, resulting in a net cash position of +$75.3M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

PROF cash on hand · 5 questions

As of December 31, 2025, Profound Medical Corp. (PROF) has $81,798,587 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $81,798,587 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $50,460,410. Data sourced from the annual 10-K filing via FMP.

PROF cash on handPROF cash reservesPROF cash 2025how much cash does PROF have

▸ Source: FMP /balance-sheet-statement · US GAAP · Profound Medical Corp. · Profound Medical Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025